Related Experiment Videos

Urinary excretion of MPTP and its primary metabolites in mice

Y S Lau1, J M Crampton, J A Wilson

  • 1Department of Pharmacology, Creighton University, Omaha, NE 68178.

Life Sciences
|January 1, 1988
PubMed

Insights

MPTP is rapidly metabolized in the periphery into MPTP N-oxide, primarily by liver enzymes. Urinary excretion of these metabolites is reduced by probenecid.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin that causes Parkinsonism.
  • Understanding MPTP metabolism is crucial for neuroprotection research.

Purpose of the Study:

  • To investigate the peripheral metabolism and urinary excretion of MPTP in mice.
  • To identify the major metabolites of MPTP and factors influencing their excretion.

Main Methods:

  • Mice were injected with radiolabeled MPTP ([3H]methyl-MPTP).
  • Urine samples were collected and analyzed using high-pressure liquid chromatography (HPLC).
  • The effect of probenecid on metabolite excretion was assessed.

Main Results:

  • Approximately 42% of injected [3H] was recovered in urine within 3 hours.
  • MPTP N-oxide was identified as the major urinary metabolite.
  • Trace amounts of MPP+ and MPTP were also detected.
  • Probenecid significantly inhibited urinary volume and MPTP metabolite excretion.

Conclusions:

  • MPTP is rapidly metabolized in the periphery, mainly by liver enzymes, to MPTP N-oxide.
  • Urinary excretion of MPTP metabolites is influenced by renal transport mechanisms, as suggested by probenecid inhibition.

Related Concept Videos